Credit Suisse is now covering Zimmer Biomet, according to a Money Flow Index Global minimally invasive neurosurgery devices market on the rise: 5 things to know.
Here are five key notes:
1. Credit Suisse gave Zimmer Biomet an "outperform" rating as the firm initiated coverage.
2. The share price target price is $107 per share.
3. Zimmer Biomet share price rose 1.06 percent on Friday and was one of the biggest gainers of the day. However, it has dropped 10.18 percent during the last three-month period.
4. The 52-week high share price is $121.84 and the 52-week low is $88.77.
5. Zimmer Biomet's market cap is $19.6 billion.